H.B. Fuller (NYSE:FUL) Price Target Cut to $72.00 by Analysts at Deutsche Bank Aktiengesellschaft

H.B. Fuller (NYSE:FUL) had its price target decreased by Deutsche Bank Aktiengesellschaft from $75.00 to $72.00 in a report released on Wednesday,Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the specialty chemicals company’s stock.

Several other brokerages have also issued reports on FUL. Citigroup reduced their target price on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Vertical Research downgraded shares of H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. Finally, JPMorgan Chase & Co. lowered their target price on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, H.B. Fuller presently has a consensus rating of “Hold” and an average target price of $75.60.

H.B. Fuller Stock Performance

FUL stock opened at $62.75 on Wednesday. H.B. Fuller has a one year low of $60.96 and a one year high of $87.67. The firm has a market cap of $3.43 billion, a price-to-earnings ratio of 27.16, a PEG ratio of 1.18 and a beta of 1.43. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.16 and a current ratio of 1.81. The firm has a 50-day simple moving average of $69.42 and a two-hundred day simple moving average of $76.30.

H.B. Fuller (NYSE:FUL) last posted its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 EPS for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The firm had revenue of $923.00 million for the quarter, compared to analysts’ expectations of $916.84 million. During the same period in the previous year, the company earned $1.32 EPS. The company’s revenue was up 2.2% on a year-over-year basis. On average, equities analysts forecast that H.B. Fuller will post 4.07 EPS for the current fiscal year.

H.B. Fuller Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 20th. Investors of record on Thursday, February 6th will be issued a dividend of $0.2225 per share. This represents a $0.89 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend is Thursday, February 6th. H.B. Fuller’s dividend payout ratio (DPR) is 38.53%.

Hedge Funds Weigh In On H.B. Fuller

A number of institutional investors have recently bought and sold shares of FUL. Lord Abbett & CO. LLC boosted its holdings in shares of H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after acquiring an additional 324,056 shares during the last quarter. Marshall Wace LLP lifted its position in H.B. Fuller by 9.9% during the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock valued at $22,319,000 after purchasing an additional 26,239 shares during the period. Geode Capital Management LLC lifted its position in H.B. Fuller by 1.5% during the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after purchasing an additional 18,734 shares during the period. Wesbanco Bank Inc. boosted its holdings in H.B. Fuller by 41.2% in the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock valued at $924,000 after purchasing an additional 4,000 shares during the last quarter. Finally, S&CO Inc. grew its position in H.B. Fuller by 0.3% during the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares during the period. 95.93% of the stock is owned by hedge funds and other institutional investors.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.